A respiratory syncytial virus vaccine (RSV vaccine) is a vaccine which prevents infection by respiratory syncytial virus. Respiratory syncytial virus (RSV) is a common and pervasive cause of acute respiratory illness.
GlaxoSmithKline, a science-led global healthcare company, on Monday announced that the Company has decided to stop enrolment and vaccination in trials evaluating its potential...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Data and Safety Monitoring Board (DSMB) for the RSV...
The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn 2023, Moderna's Chief Executive Officer...